BIOMAT Database Logo BIOMAT Database Logo

Bone repair in cyclosporin treated renal transplant patients. 1989

J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Department of Medicine, Academic Medical Centre, Amsterdam, The Netherlands.

UI MeSH Term Description Entries
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D001862 Bone Resorption Bone loss due to osteoclastic activity. Bone Loss, Osteoclastic,Osteoclastic Bone Loss,Bone Losses, Osteoclastic,Bone Resorptions,Loss, Osteoclastic Bone,Losses, Osteoclastic Bone,Osteoclastic Bone Losses,Resorption, Bone,Resorptions, Bone
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.

Related Publications

J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Acute bone-marrow oedema in cyclosporin-treated renal transplant recipients.
May 1997, QJM : monthly journal of the Association of Physicians,
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Bone histology in renal transplant patients receiving cyclosporin.
May 1988, Lancet (London, England),
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Skin cancer in renal transplant patients treated with cyclosporin.
January 1985, Lancet (London, England),
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Pituitary-testicular function in cyclosporin-treated renal transplant patients.
January 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Oxidative stress in cyclosporin and azathioprine treated renal transplant patients.
August 1997, Clinica chimica acta; international journal of clinical chemistry,
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Erythraemia in renal transplant recipients treated with cyclosporin.
June 1988, Lancet (London, England),
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Magnesium in cyclosporin-treated kidney transplant patients.
January 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients.
January 1986, Dermatologica,
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Early proteinuria in renal transplant recipients treated with cyclosporin.
February 1999, Transplantation,
J M Wilmink, and J Bras, and S Surachno, and J L van Heyst, and J M van der Horst
Cyclosporin-erythromycin interaction in renal transplant patients.
April 1989, British journal of clinical pharmacology,
Copied contents to your clipboard!